IN2013MU01510A - - Google Patents

Info

Publication number
IN2013MU01510A
IN2013MU01510A IN1510MU2013A IN2013MU01510A IN 2013MU01510 A IN2013MU01510 A IN 2013MU01510A IN 1510MU2013 A IN1510MU2013 A IN 1510MU2013A IN 2013MU01510 A IN2013MU01510 A IN 2013MU01510A
Authority
IN
India
Prior art keywords
relates
bendamustine
treatment
nitrogen
disease states
Prior art date
Application number
Inventor
Rajesh Jain
Sing Sarabjith
Vipul Bhatt Sivagami
Dhanvantrao Shinde Dinesh
Original Assignee
Panacea Biotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacea Biotec Ltd filed Critical Panacea Biotec Ltd
Priority to IN1510MU2013 priority Critical patent/IN2013MU01510A/en
Publication of IN2013MU01510A publication Critical patent/IN2013MU01510A/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

The present invention relates to lyophilized pharmaceutical compositions for the treatment of various disease states, especially neoplastic diseases and autoimmune diseases. Particularly, it relates to pharmaceutical formulations comprising nitrogen mustards, particularly the nitrogen mustard bendamustine, e.g., bendamustine hydrochloride.
IN1510MU2013 2013-04-25 2013-04-25 IN2013MU01510A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN1510MU2013 IN2013MU01510A (en) 2013-04-25 2013-04-25

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1510MU2013 IN2013MU01510A (en) 2013-04-25 2013-04-25

Publications (1)

Publication Number Publication Date
IN2013MU01510A true IN2013MU01510A (en) 2015-04-17

Family

ID=54394694

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1510MU2013 IN2013MU01510A (en) 2013-04-25 2013-04-25

Country Status (1)

Country Link
IN (1) IN2013MU01510A (en)

Similar Documents

Publication Publication Date Title
JOP20200192A1 (en) Anti-tigit antibodies
TW201613901A (en) New compounds
UA116648C2 (en) FUMARATS AS A PRODUCT AND THEIR USE IN THE TREATMENT OF DIFFERENT DISEASES
PH12016501122A1 (en) Delayed release compositions of linaclotide
HN2012000023A (en) COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITARY DISEASES
MY186047A (en) Eutectic formulations of cyclobenzaprine hydrochloride
EA201690513A1 (en) COMBINATION OF MEK INHIBITOR AND ERK INHIBITOR FOR USE IN THE TREATMENT OF HYPERPROLIFERATIVE DISEASES
IN2013MU03583A (en)
IN2014MN02236A (en)
TR201910866T4 (en) Combined preparations for cancer treatment.
EA201591758A8 (en) Sub-ADAMTS13 INTRODUCTION
MX2017012596A (en) A pharmaceutical composition and the use thereof.
MX2021002633A (en) Bendamustine solid dispersions and continuous infusion.
EA201591717A1 (en) Solid Forms of Vumurafenib Hydrochloride
TR201905218T4 (en) USEFUL VITANOLIDES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES.
NZ737410A (en) Compositions comprising anakinra
PH12017501979A1 (en) Pharmaceutical compound
WO2014170769A3 (en) Bendamustine lyophilized pharmaceutical compositions
IN2013MU01510A (en)
EA201791648A1 (en) HYALURONIC ACID AND MACROGOL COMBINATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
WO2015003049A3 (en) Compositions and methods to treat inflammatory joint disease
IN2014KN02584A (en)
EA201991733A1 (en) PHARMACEUTICAL COMPOSITIONS FOR COMBINED THERAPY
TR201721065A2 (en) Lyophilized pharmaceutical formulations comprising dexmedetomidine
IN2014CH00035A (en)